Showing results (1-10 of 61) with videos related to

Sort By:
Pageof 7
Current Infectious Disease Reports|November 11, 2016
Thoughts Around the Zika Virus CrisisDidier Musso, Marion C Lanteri
Transfusion|January 21, 2020
Inactivation of yellow fever virus with amotosalen and ultraviolet A light pathogen-reduction technologyYvette A Girard, Felicia Santa Maria, Marion C Lanteri
Lancet (London, England)|June 26, 2017
An update on Zika virus infectionDavid Baud, Duane J Gubler, Bruno Schaub, et al.
Medecine Sciences : M/S|April 29, 2011
[West Nile virus. II. Immunopathophysiology in humans]Marion C Lanteri, Michael S Diamond, Philip J Norris, et al.
Transfusion|September 19, 2017
Pathogen inactivation of Dengue virus in red blood cells using amustaline and glutathioneMaite Aubry, Andrew Laughhunn, Felicia Santa Maria, et al.
Transfusion|January 12, 2018
Inactivation of chikungunya virus in blood components treated with amotosalen/ultraviolet A light or amustaline/glutathioneAndrew Laughhunn, Yan-Jang S Huang, Dana L Vanlandingham, et al.
Transfusion|July 4, 2017
Inactivation of Zika virus in platelet components using amotosalen and ultraviolet A illuminationFelicia Santa Maria, Andrew Laughhunn, Marion C Lanteri, et al.
Scientific Reports|November 22, 2019
Differential Pattern of Soluble Immune Markers in Asymptomatic Dengue, West Nile and Zika Virus InfectionsRafaelle Fares-Gusmao, Bruno Coelho Rocha, Emilia Sippert, et al.
Transfusion and Apheresis Science : Official Journal of the World Apheresis Association : Official Journal of the European Society for Haemapheresis|December 24, 2018
In vitro evaluation of pathogen inactivated platelet quality: An 8 year experience of routine use in Galicia, SpainAzucena Castrillo Fernández, Marion C Lanteri, Carina Arcas Otero, et al.
Transfusion|February 7, 2017
Amustaline (S-303) treatment inactivates high levels of Zika virus in red blood cell componentsAndrew Laughhunn, Felicia Santa Maria, Julien Broult, et al.
Pageof 7